Testing effectiveness (Phase 2)Study completedNCT02646163
What this trial is testing
Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients
Who this might be right for
Hepatitis B, Chronic
Replicor Inc. 8
Showing 20 of 0 results